Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Sen. Durbin, Richard J. [D-IL]

Sen. Durbin, Richard J. [D-IL]

United States · Official source

Records

11,330 records where Sen. Durbin, Richard J. [D-IL] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· SS. 2963 (119th)referred

Fair Pay for Federal Contractors Act of 2025

United States · United States Congress · 1 October 2025

Fair Pay for Federal Contractors Act of 2025 This bill provides back pay to employees of federal contractors who lost pay due to a lapse in appropriations (i.e., government shutdown) in FY2026. Specifically, the bill provides appropriations for federal agencies that are subject to a lapse in appropriations in FY2026 to adjust the price of contracts to compensate federal contractors for providing back pay to employees who were affected by the lapse in appropriations.  The agencies must adjust the price of any contract for which the contractor stopped, suspended, delayed, or interrupted all or part of the work under the contract due to the lapse in appropriations. The price adjustment must compensate the contractor for reasonable costs incurred to (1) compensate employees who were furloughed or laid off, were not working, or experienced a reduction of hours or compensation due to the lapse in appropriations; or (2) restore paid leave taken by employees during the lapse in appropriations if the contractor required or permitted employees to use paid leave as a result of the lapse in appropriations. The maximum amount of weekly compensation of an employee for which an adjustment may be made under this bill may not exceed the lesser of (1) the employee's actual weekly compensation, or (2) $1,442 (or a lesser amount pro-rated for an employee who works less than 40 hours per week). The bill also requires the Office of Federal Procurement Policy to submit a report to Congress on the adjustments made under this bill.

Bill· SJRESS.J.Res. 84 (119th)failed

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".

United States · United States Congress · 30 September 2025

This joint resolution nullifies the rule titled Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability , which was issued by the Centers for Medicare & Medicaid Services on June 25, 2025.  The rule makes several changes to enrollment requirements for health insurance exchanges, including (1) requiring annual open enrollment periods for all exchanges to begin by November 1 and end by December 31, (2) requiring all exchanges to conduct pre-enrollment verification of eligibility for at least 75% of new enrollments through special enrollment periods, and (3) prohibiting Deferred Action for Childhood Arrivals (DACA) recipients from enrolling in plans through exchanges or in state Basic Health Programs (state programs for certain low-income residents). The rule also prohibits individual and small group health insurers from covering certain sex-trait modification procedures as an essential health benefit.

Bill· SS. 2937 (119th)referred

AI LEAD Act

United States · United States Congress · 29 September 2025

Bill· SS. 2915 (119th)referred

SPUR Housing Act

United States · United States Congress · 19 September 2025

Resolution· SRESS.Res. 408 (119th)referred

A resolution recognizing September 20, 2025, as "National LGBTQ+ Servicemembers and Veterans Day".

United States · United States Congress · 18 September 2025

This resolution recognizes September 20, 2025, as National LGBTQ+ Servicemembers and Veterans Day and celebrates the contributions of lesbian, gay, bisexual, transgender, and queer servicemembers and veterans who have served in the Armed Forces. Additionally, the resolution (1) regrets the harm done to such servicemembers and veterans under policies that discriminate based on sexual orientation and gender identity, and (2) urges the Department of Veterans Affairs and Department of Defense to ensure transgender veterans and servicemembers and their families have access to a full range of health care.

Bill· SS. 2862 (119th)referred

CCAMPIS Reauthorization Act

United States · United States Congress · 18 September 2025

Child Care Access Means Parents In Schools Reauthorization Act or the CCAMPIS Reauthorization Act This bill reauthorizes through FY2031 and revises the Child Care Access Means Parents in School Program. The program awards grants to support the participation of eligible low-income parents in postsecondary education through the provision of campus-based child care services. Among other revisions to the program, the bill increases the minimum and maximum grant amounts, allows grant funds to be used for additional purposes (e.g., child care subsidies and support services), and specifies additional grant application requirements.

Bill· SS. 2863 (119th)referred

RRLEF Act of 2025

United States · United States Congress · 18 September 2025

Bill· SS. 2837 (119th)referred

Protect America’s Workforce Act

United States · United States Congress · 17 September 2025

Protect America's Workforce Act This bill nullifies two executive orders: Exclusions from Federal Labor-Management Relations Programs (issued on March 27, 2025) and Further Exclusions From the Federal Labor- Management Relations Program (issued on August 28, 2025). The executive orders exclude specified executive branch agencies and subdivisions from the Federal Service Labor-Management Relations Statute and the Foreign Service Labor-Management Relations Statute. The statutes authorize federal employees' participation in collective bargaining and enforce collective bargaining rights.  The bill also specifies that a collective bargaining agreement that is in place as of March 26, 2025, and is between an executive branch agency and any labor organization that is an exclusive representative of federal employees, shall have full force and effect through the stated term of the agreement.

Resolution· SRESS.Res. 390 (119th)referred

A resolution designating September 2025 as "National Voting Rights Month".

United States · United States Congress · 16 September 2025

This resolution designates September 2025 as National Voting Rights Month, encourages people to uphold the right to vote, encourages Congress to pass certain voting rights legislation, recommends the development of a curriculum in public schools and universities regarding voting, expresses appreciation for the U.S. Postal Service having issued a special Representative John R. Lewis stamp, and invites Congress to allocate funds for public service announcements regarding elections.

Bill· SS. 2822 (119th)referred

Register America to Vote Act of 2025

United States · United States Congress · 16 September 2025

Register America to Vote Act of 2025 This bill provides for the automatic registration of eligible voters. Specifically, the bill directs each state that has a voter registration requirement for federal elections to automatically register eligible individuals when they turn 18 years of age. The bill also provides for the automatic registration of individuals through state motor vehicle authorities. Individuals must be provided with an opportunity to opt out of automatic voter registration. The Election Assistance Commission must make grants to states to implement these automatic voter registration programs.

Bill· SS. 2823 (119th)referred

FAMILY Act

United States · United States Congress · 16 September 2025

Resolution· SRESS.Res. 389 (119th)referred

A resolution condemning the extreme anti-vaccine policies of Secretary of Health and Human Services Robert F. Kennedy, Jr., strongly opposing the policies of the State of Florida that roll back immunization requirements, and expressing the sense of the Senate that vaccines are critical to protecting public health, eliminating preventable illness and death, and reducing hospitalizations and severity of illness, work best when adopted at a high level within each community, and must be made available to the public.

United States · United States Congress · 16 September 2025

Bill· SS. 2803 (119th)referred

SUN Act

United States · United States Congress · 15 September 2025

Bill· SS. 2799 (119th)referred

Forced Arbitration Injustice Repeal Act

United States · United States Congress · 15 September 2025

Forced Arbitration Injustice Repeal Act This bill prohibits a predispute arbitration agreement from being valid or enforceable if it requires arbitration of an employment, consumer, antitrust, or civil rights dispute.

Bill· SS. 2620 (119th)referred

REMEDY Act

United States · United States Congress · 31 July 2025

Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act This bill limits the scope of a 30-month stay on approval of a generic drug by the Food and Drug Administration (FDA) while patent litigation involving the reference (brand-name) drug is ongoing. Generally, entities seeking approval of a new drug must provide the FDA with information on patents claiming the drug or a method of use. Entities seeking approval of a generic drug must certify for each such patent on the reference drug that (1) the patent has expired or will expire before the generic is marketed, or (2) the patent is invalid or inapplicable to the generic drug. If a generic drug applicant certifies that a patent is invalid or inapplicable and a patent infringement suit is timely brought, the FDA is prohibited from approving the generic for 30 months (unless the patent litigation is resolved sooner). Under current law, this 30-month stay applies to patent litigation on any number of patents on a reference drug, provided the patent information was filed with the FDA before the generic application. Under the bill, when an entity applies to the FDA for approval of a new drug, the entity must select only one patent to be eligible for the 30-month stay. This selection may not be changed or amended. After the bill’s enactment, only patent litigation related to the reference drug’s selected patent may trigger the 30-month stay on approval of a generic.

Bill· SS. 2594 (119th)referred

IEIS Act

United States · United States Congress · 31 July 2025